EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Abliva AB's enterprise value is kr189.27 Mil.
Abliva AB's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.14 Mil. Therefore, Abliva AB's EV-to-Revenue for today is 1,381.55.
The historical rank and industry rank for Abliva AB's EV-to-Revenue or its related term are showing as below:
OSTO:ABLI'
s EV-to-Revenue Range Over the Past 10 Years
Min: -30.35 Med: 256.1 Max: 9400.02
Current: 1381.55
During the past 13 years, the highest EV-to-Revenue of Abliva AB was 9400.02. The lowest was -30.35. And the median was 256.10.
OSTO:ABLI's EV-to-Revenue is ranked worse than 95.58% of 1040
companies
in the Biotechnology industry
Industry Median: 8.12
vs OSTO:ABLI: 1381.55
As of today (2024-05-23), Abliva AB's stock price is kr0.183.
Abliva AB's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.00. Therefore, Abliva AB's PS Ratio for today is .
Abliva AB EV-to-Revenue Historical Data
The historical data trend for Abliva AB's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Abliva AB's EV-to-Revenue
For the Biotechnology subindustry, Abliva AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abliva AB's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Abliva AB's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Abliva AB's EV-to-Revenue falls into.
Abliva AB's current Enterprise Value is kr189.27 Mil.
Abliva AB's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.14 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abliva AB's share price for today is kr0.183.
Abliva AB's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abliva AB EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Abliva AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Abliva AB is a Swedish company that is active in pharmaceutical development. It develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare, and often very severe diseases occur when the cell's energy provider, the mitochondria, does not function properly. The portfolio includes projects at different stages and ranges from the early discovery phase to the clinical phase.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSTO:ABLI has been successfully added to your 